Pilocarpine, Brimonidine, Oxymetazoline (PBO) Compound to Control Presbyopia Symptoms
Clinical trial NCT05006911 · UNKNOWN
Trial details
- NCT number
- NCT05006911
- Sponsor
- Optall Vision
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-14
- Primary completion
- 2021-09-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.